We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

ARKRAY

ARKRAY develops, manufactures, and distributes sample test devices, diagnostic regents, and diagnostic support tools ... read more Featured Products: More products

Download Mobile App




PT/INR Monitoring System Uses Novel Clot-Detection Technology to Deliver Results at POC

By LabMedica International staff writers
Posted on 13 Jul 2023
Print article
Image: Assure PT Care is a point-of-care test that measures the time it takes blood to clot (Photo courtesy of CoaguSense)
Image: Assure PT Care is a point-of-care test that measures the time it takes blood to clot (Photo courtesy of CoaguSense)

For precise determination of prothrombin time, medical professionals and researchers often rely on either the World Health Organization (WHO) mechanical tilt tube technique or the Fibrometer. Both methods utilize a mechanical process to directly identify clot formation but can be complex to perform. Now, an advanced PT/INR Monitoring System marks a significant breakthrough in point-of-care prothrombin time monitoring technology, thanks to its miniaturization and simplification of the direct mechanical clot detection process.

ARKRAY USA, Inc. (Kyoto, Japan), in a strategic partnership with CoaguSense, Inc. (Fremont, CA, USA), has launched the Assure PT Care PT/INR Monitoring System. ARKRAY USA is the sole distributor of Assure PT Care, a point-of-care test that measures the clotting time of blood utilizing a patented micromechanical system. The system's results are comparable to those of the gold-standard WHO tilt-tube method and are reported in PT seconds and INR with the highest levels of accuracy and precision. Instant results are crucial for effectively monitoring patients on anticoagulation therapy, enabling optimal care decisions. The Assure PT Care system, which is wireless, enhances operational efficiency for PT/INR testing and offers immediate results, facilitating prompt treatment decisions. It is certified for professional use in a CLIA-waived setting and offers the benefits of being compact and easy to use.

"ARKRAY is committed to offering reliable and cost-effective solutions to our long-term care customers," said Tadashi Inoue, Chief Executive Officer of ARKRAY USA. "We are excited to broaden and diversify our product offering with Assure PT Care to continue serving our customers with a brand they know and trust for reliability, quality, and excellent service."

Related Links:
ARKRAY USA, Inc. 
CoaguSense, Inc. 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.